• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl halides

Comprehensive Overview of 2,3-Difluoro-4-(fluoromethyl)toluene (CAS No. 1806306-09-1): Properties, Applications, and Industry Trends

2,3-Difluoro-4-(fluoromethyl)toluene (CAS No. 1806306-09-1) is a fluorinated aromatic compound gaining attention in advanced chemical research and industrial applications. With its unique molecular structure featuring fluorine substituents and a fluoromethyl group, this compound exhibits remarkable properties for use in pharmaceuticals, agrochemicals, and specialty materials. The growing demand for fluorinated building blocks in drug discovery and the shift toward sustainable fluorination methods have positioned this chemical as a subject of significant scientific interest.

The compound's structural versatility allows it to serve as a key intermediate in synthesizing bioactive molecules. Researchers are particularly interested in its potential for hydrogen bonding interactions and lipophilicity modulation, which are critical factors in medicinal chemistry. Recent studies highlight its utility in developing next-generation pharmaceuticals, especially in CNS-targeting drugs where fluorine incorporation enhances blood-brain barrier penetration. The electron-withdrawing effects of its fluorine atoms also make it valuable for creating high-performance materials with improved thermal and chemical stability.

From an industrial perspective, 2,3-Difluoro-4-(fluoromethyl)toluene aligns with the global push for green chemistry solutions. Manufacturers are adopting catalytic fluorination techniques to produce such compounds with reduced environmental impact. This approach addresses two major industry concerns: process safety and waste minimization. The compound's stability under various conditions makes it suitable for scalable production, meeting the pharmaceutical industry's need for high-purity intermediates.

Analytical characterization of CAS 1806306-09-1 typically involves advanced techniques like NMR spectroscopy (particularly ¹⁹F NMR) and mass spectrometry. These methods confirm the regioselective fluorination pattern and purity level, which are crucial for research applications. The compound's physicochemical properties, including its boiling point, solubility profile, and partition coefficient, make it compatible with various organic synthesis protocols while maintaining excellent storage stability.

Emerging applications for 2,3-Difluoro-4-(fluoromethyl)toluene include its use in liquid crystal formulations for electronic displays and as a modifier in advanced polymer systems. The fluorine-rich structure contributes to desired material characteristics such as low surface energy and enhanced durability. These properties are particularly valuable in developing water-repellent coatings and specialty adhesives for harsh environments.

Quality control standards for 1806306-09-1 have become increasingly stringent, reflecting the compound's importance in high-value applications. Reputable suppliers now provide comprehensive analytical certificates detailing isomeric purity and impurity profiles. The market has seen growing demand for custom fluorination services to produce derivatives of this compound, catering to specific research needs in drug discovery pipelines and material science innovations.

Future research directions for 2,3-Difluoro-4-(fluoromethyl)toluene may explore its potential in metal-organic frameworks (MOFs) and catalytic systems. The compound's ability to influence electronic properties through fluorine substitution effects makes it interesting for energy storage applications. Additionally, its role in PET radiopharmaceuticals (where fluorine-18 labeling is crucial) represents another promising avenue, aligning with the expanding theranostics market.

For researchers working with fluorinated aromatic compounds, proper handling protocols should always be followed, despite the compound's favorable safety profile. Standard laboratory precautions for organic solvents apply, with particular attention to ventilation requirements when scaling up reactions. The development of continuous flow processes for its synthesis demonstrates how modern chemical engineering can optimize production of such valuable fluorine-containing intermediates.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)